These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 475844)

  • 1. Dopamine uptake inhibitors and releasing agents differentiated by the use of synaptosomes and field-stimulated brain slices in vitro.
    Hunt P; Raynaud JP; Leven M; Schacht U
    Biochem Pharmacol; 1979 Jul; 28(13):2011-6. PubMed ID: 475844
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of (3H)-dopamine uptake into rat brain synaptosomes by the new non-tricyclic antidepressants, FS32 and FS97.
    Koide T; Uyemura K
    Eur J Pharmacol; 1980 Mar; 62(2-3):147-55. PubMed ID: 7379837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrahydropapaveroline inhibits dopamine uptake in rat brain synaptosomes.
    Shier WT; Rossier J; Koda LY; Bloom FE
    Adv Exp Med Biol; 1980; 132():807-12. PubMed ID: 7424742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steric requirements for catecholamine uptake by rat brain synaptosomes: studies with rigid analogs of amphetamine.
    Horn AS; Snyder SH
    J Pharmacol Exp Ther; 1972 Mar; 180(3):523-30. PubMed ID: 5012779
    [No Abstract]   [Full Text] [Related]  

  • 5. Forskolin stimulates the conversion of tyrosine to dopamine in catecholaminergic neural tissue.
    Katz IR; Smith D; Makman MH
    Brain Res; 1983 Mar; 264(1):173-7. PubMed ID: 6303497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amantadine and catecholamine uptake.
    Herblin WF
    Biochem Pharmacol; 1972 Jul; 21(14):1993-5. PubMed ID: 4649347
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences in the inhibitory effect of Cd2+, Mn2+ and Al3+ on the uptake of dopamine by synaptosomes from forebrain and from striatum of the rat.
    Lai JC; Lim L; Davison AN
    Biochem Pharmacol; 1981 Nov; 30(22):3123-5. PubMed ID: 6279103
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of synaptosomal uptake of norepinephrine and dopamine by conformationally restricted sympathomimetic amines.
    Komiskey HL; Hsu FL; Bossart FJ; Fowble JW; Miller DD; Patil PN
    Eur J Pharmacol; 1978 Nov; 52(1):37-45. PubMed ID: 720387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of apomorphine in vitro on the uptake and release of catecholamines in crude synaptosomal preparations of rat striatum and hypothalamus.
    Ferris RM; Tang FL; Russell AV
    Biochem Pharmacol; 1975 Aug; 24(16):1523-7. PubMed ID: 1191310
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitory effects of type A and type B monoamine oxidase inhibitors on synaptosomal accumulation of [3H]dopamine: a reflection of antidepressant potency.
    Azzaro AJ; Demarest KT
    Biochem Pharmacol; 1982 Jun; 31(12):2195-7. PubMed ID: 7115440
    [No Abstract]   [Full Text] [Related]  

  • 11. The release of dopamine from synaptosomes from rat striatum by the ionophores X 537A and A 23187.
    Holz RW
    Biochim Biophys Acta; 1975 Jan; 375(1):138-52. PubMed ID: 1111574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The release of endogenous 3,4-dihydroxyphenethylamine from synaptosomes isolated from corpus striatum,
    De Belleroche JA; Bradford HF
    Biochem Soc Trans; 1975; 3(1):99-101. PubMed ID: 1126552
    [No Abstract]   [Full Text] [Related]  

  • 13. Potassium-induced release of 14C-dopamine from synaptosomes of corpus striatum of rats: effects of morphine.
    Bosse A; Kuschinsky K
    Arzneimittelforschung; 1978; 28(11):2100-2. PubMed ID: 582913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basis of phencyclidine's ability to decrease the synaptosomal accumulation of 3H-catecholamines.
    Ary TE; Komiskey HL
    Eur J Pharmacol; 1980 Feb; 61(4):401-5. PubMed ID: 7371716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar potency ratios of amphetamine optical isomers for inhibition of dopamine uptake by synaptosomes of corpus striatum, olfactory tubercle and prefrontal cortex of the rat.
    Matthews RT; Shore PA
    Biochem Pharmacol; 1984 Sep; 33(17):2817-9. PubMed ID: 6466390
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes.
    Poddar MK; Dewey WL
    J Pharmacol Exp Ther; 1980 Jul; 214(1):63-7. PubMed ID: 7391971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of benapyrzine, a new antiparkinson drug, on dopamine uptake into corpus striatum.
    Palfreyman MG; Palfreyman ES; Clark MS
    Eur J Pharmacol; 1974 Oct; 28(2):379-83. PubMed ID: 4418659
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of [3H]dopamine accumulation in rat striatal synaptosomes by psychotropic drugs.
    Hyttel J
    Biochem Pharmacol; 1978 Apr; 27(7):1063-8. PubMed ID: 656154
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of dibutyryl cyclic AMP, theophylline and papaverine on the release of 3H-catecholamines from rat brain striatal and cortical synaptosomes.
    Eitan A; Hershkowitz M
    Eur J Pharmacol; 1977 Dec; 46(4):323-7. PubMed ID: 201472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of benztropine and nomifensine on dopamine uptake and release from striatal synaptosomes.
    McKillop D; Bradford HF
    Biochem Pharmacol; 1981 Oct; 30(20):2753-8. PubMed ID: 7317073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.